title: [Results of hearing preservation in surgery of vestibular schwannoma. Value of combined retrosigmoid and middle fossa approaches].
abstract: We report our experience of hearing preservation in acoustic neurinoma surgery, using combined retrosigmoid and middle fossa approaches. Fifty neurinomas operated on between 1987 and 1994 were included in this retrospective study. Hearing preservation surgery was performed for patients with grade II or grade III tumors (mean average tumor diameter: 14.4 mm), presenting with normal or serviceable pre-operative hearing (pure tonal average decrease less than 50 dB, speech discrimination score better than 50%). Isolated middle fossa approach was used in 3 cases, isolated retrosigmoid approach in 2 cases. The 45 other cases were operated on using both routes during the same procedure. Total removal of the tumor with anatomic facial preservation was performed in all cases. No death occurred. The facial function assessed 3 months after surgery was good in 84% of cases (House-Brackmann grades I or II). The mean follow-up was 42 months. Post-operative hearing was measurable in 48% of cases and serviceable in 30% of cases. The size of the tumor and the level of preoperative hearing appear to be the most important predictive criteria for successful hearing preservation.
authors.affiliation: Clinique Neurochirurgicale, Hôpital Roger-Salengro, CHRU, Lille.
authors.forename: E
authors.initials: E
authors.lastname: Louis
authors.forename: J P
authors.initials: JP
authors.lastname: Lejeune
authors.forename: F M
authors.initials: FM
authors.lastname: Vaneecloo
authors.forename: C
authors.initials: C
authors.lastname: Vincent
authors.forename: A
authors.initials: A
authors.lastname: Angot
authors.forename: J L
authors.initials: JL
authors.lastname: Christiaens
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001299:Audiometry; D005260:Female; D006309:Hearing; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D009464:Neuroma, Acoustic / Q000601:surgery*; D011379:Prognosis